ACS: The more things change the more they stay the same
| Sunday, May 4, 2025 |
| 11:45 AM - 12:30 PM |
| Grand Ballroom |
Overview
Joanne Gross
Details
Every day, 250 Australians are hospitalised for an acute coronary syndrome (ACS). In March 2025, new Australian clinical guidelines for diagnosing and managing ACS will be released. This session will summarise key changes in the guidelines and the evidence underpinning those changes so consultant pharmacists can incorporate these changes into their practice and to the care of patients. Equally as important, many of the core principles of ACS management remain the same but it is common that guideline recommended therapy is not fully implemented so this session will outline common medicine management issues following ACS for consultant pharmacists to actively monitor and manage.
Learning objectives:
1. Discuss new guideline recommendations for therapies to reduce the risk of ACS.
2. Identify common medicine management issues in patients with a history of ACS.
3. Discuss an individualised approach to secondary prevention of ACS.
4. Recognise resources available to support patients to implement healthy behaviour changes following an ACS.
Competency standards (2016): 1.6, 3.5
Speaker
Ms Joanne Gross
QUM Pharmacist
Department of Health Tasmania
ACS: The more things change the more they stay the same
Biography
Joanne is a Quality Use of Medicines (QUM) Pharmacist at the Department of Health Tasmania, an HMR-credentialed pharmacist and current PSA Tasmania Branch Vice President.
Joanne previously worked in Cardiology and Coronary Care Units at the Royal North Shore hospital in Sydney and served on the SHPA Cardiology Specialty Practice Leadership Committee. Joanne has worked in Medical Information and Pharmacovigilance for Boehringer Ingelheim and their diabetes medicines and has delivered several cardiovascular and kidney disease educational visiting programs to hundreds of health professionals as a previous NPS MedicineWise educational visitor.
